Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVOTHYROXINE Cause Transient ischaemic attack? 517 Reports in FDA Database

Thyroid Balance & Feminine Wellness

Thyrafemme Balance — 14 gentle ingredients for energy, mood & hormonal harmony.

Discover Thyrafemme

According to the FDA Adverse Event Reporting System (FAERS), 517 reports of Transient ischaemic attack have been filed in association with LEVOTHYROXINE (LEVOTHYROXINE SODIUM). This represents 0.8% of all adverse event reports for LEVOTHYROXINE.

517
Reports of Transient ischaemic attack with LEVOTHYROXINE
0.8%
of all LEVOTHYROXINE reports
23
Deaths
209
Hospitalizations

How Dangerous Is Transient ischaemic attack From LEVOTHYROXINE?

Of the 517 reports, 23 (4.4%) resulted in death, 209 (40.4%) required hospitalization, and 129 (25.0%) were considered life-threatening.

Is Transient ischaemic attack Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVOTHYROXINE. However, 517 reports have been filed with the FAERS database.

What Other Side Effects Does LEVOTHYROXINE Cause?

Fatigue (10,494) Headache (6,425) Insomnia (4,663) Drug ineffective (4,556) Alopecia (4,491) Weight increased (4,130) Nausea (4,013) Palpitations (3,825) Dizziness (3,761) Asthenia (3,694)

What Other Drugs Cause Transient ischaemic attack?

APIXABAN (1,157) RIVAROXABAN (820) LENALIDOMIDE (655) ADALIMUMAB (604) ASPIRIN (587) ROSIGLITAZONE (585) NAPROXEN (521) DABIGATRAN ETEXILATE (471) CLOPIDOGREL BISULFATE (454) SIMVASTATIN (415)

Which LEVOTHYROXINE Alternatives Have Lower Transient ischaemic attack Risk?

LEVOTHYROXINE vs LEVOTHYROXINE\LEVOTHYROXINE LEVOTHYROXINE vs LEVOTHYROXINE\LIOTHYRONINE LEVOTHYROXINE vs LEVOXYL LEVOTHYROXINE vs LEXAPRO LEVOTHYROXINE vs LEXISCAN

Related Pages

LEVOTHYROXINE Full Profile All Transient ischaemic attack Reports All Drugs Causing Transient ischaemic attack LEVOTHYROXINE Demographics